Tony Ezell serves as the executive vice president, president of the Americas for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he leads the company’s U.S., Canada, and Latin American regions, and is responsible for an integrated commercialization approach to prioritizing and delivering on customer needs. He is also a member of the BD Executive Leadership Team.
Prior to BD, Ezell spent more than 27 years at Eli Lilly and Co., where he built a strong track record in sales, marketing, and business leadership, having led U.S. hospital businesses before assuming the role of chief customer officer. He went on to serve as chief marketing officer for Lilly’s Elanco Animal Health business prior to its spinoff and also led Lilly’s U.S. Connected Care and Insulins business as VP/GM.
Ezell has global operational experience, having lead organizations as large as 1,200 individuals strong. Additionally, he has a passion for people, as demonstrated by his history of building high-performing teams and by his history of developing deep customer understanding and translating those insights into meaningful brand campaigns. He is experienced in leading major transformation efforts that span business units, functions, and geographies.
Tony currently serves on the boards of the Association of National Advertisers (ANA) and the Coalition to Strengthen Americans Healthcare. He is a former member of the Board of Trustees for Brebeuf Jesuit High School, the Board of Directors for the Catholic Medical Mission Board, and the KPMG Healthcare Advisory Board. He is also the former Chairman of the UNCF Indianapolis Leadership Council. He served on the Board of Directors for the Health Forum, Inc. from 2006 to 2012.
He has a degree in Business Administration from the School of Business and Industry (SBI) at Florida A & M University and an MBA from the Kellogg School of Management at Northwestern University.
